Substance / Medication

Equine diphtheria antitoxin

Overview

Active Ingredient
equine diphtheria antitoxin
RxNorm CUI
91602

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.
Van den Steen Peter, Cheuvart Brigitte, Deraedt Quentin et al. · Hum Vaccin Immunother · 2023
PMID: 36746754Meta-AnalysisFull text (PMC)
Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
Crawford Lori, Halperin Scott A, Dzierlenga Michael W et al. · Environ Int · 2023
PMID: 36764183Meta-Analysis
Waning Immunity After Receipt of Pertussis, Diphtheria, Tetanus, and Polio-Related Vaccines: A Systematic Review and Meta-analysis.
Gao Huizhi, Lau Eric H Y, Cowling Benjamin J · J Infect Dis · 2022
PMID: 34543411Meta-Analysis
What is the true burden of diphtheria, tetanus, pertussis and poliovirus in children aged 3-18 years in Asia? A systematic literature review.
Nicholson Lindsay, Adkins Elizabeth, Karyanti Mulya Rahma et al. · Int J Infect Dis · 2022
PMID: 35077880Meta-Analysis
Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis.
Gidengil Courtney, Goetz Matthew Bidwell, Newberry Sydne et al. · Vaccine · 2021
PMID: 34049735Meta-Analysis
[Normal immunoglobulin might replace unavailable equine diphtheria antitoxin].
Chrdle A · Klin Mikrobiol Infekc Lek · 2014
PMID: 24992740Other
Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.
Sevigny Leila M, Booth Brian J, Rowley Kirk J et al. · Infect Immun · 2013
PMID: 23940209PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Equine diphtheria antitoxin (substance)
SNOMED CT
871546003
UMLS CUI
C0305057
RxNorm CUI
91602

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.